Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1129-1136

  Davies, Simon R ^a   Davies, Mansel Leigh ^a   Sanders, Andrew ^a   Parr, Chris ^a   Torkington, Jared ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

CCN; Colorectal cancer; WISP 1; WISP 2; WISP 3

Indexed keywords

CYSTEINE RICH PROTEIN 61; PROTEIN WISP 1; PROTEIN WISP 2; PROTEIN WISP 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA PRIMERS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 77950453670     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000595     Document Type: Article

References (32)

1. Planque N and Perbal B: A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 3: 15-30, 2003.
2. Nusse R and Varmus H: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109, 1982.
3. Ooyen V and Nusse R: Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell 39: 233-240, 1984.
4. Tsukamoto A, Grosschedl R, Guzman R, Parslow T and Varmus H: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625, 1988.
5. Pennica D, Swanson T, Welsh J, et al: WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1 transformed cells and aberrantly expressed in human colon tumours. Proc Natl Acad Sci USA 95: 14717-14722, 1998.
6. Bringstock D: The CCN family: a new stimulus package. J Endocrinol 178: 169-175, 2003.
7. Perbal B, Brigstock D and Lau L: Report on the second international workshop on the CCN family of genes. Mol Pathol 56: 80-85, 2003.
8. Khor T, Gul Y, Ithnin H and Seow H: A comparative study of the expression of Wnt-1, WISP-1, surviving and cyclin-D1 in colorectal cancer. Int J Colorectal Dis 21: 291-300, 2006.
9. Soon L, Yie T, Shvarts Levine A, Su F and Tchou-Wong K: Overexpression of WISP-1 down regulated motility and invasion of lung cancer cells through inhibition of rac activation. J Biol Chem 278: 11465-11470, 2003.
10. Su F, Overholtzer M, Besser D and Levine A: WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev16: 46-57, 2002.
11. Banerjee S, Sengupta K, Saxena N, Dhar K and Banerjee S: Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-α-positive breast tumour calls through multipul modular cross-talks. Mol Cancer Res 3: 151-162, 2003.
12. Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo M and Banerjee S: WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5: 63-73, 2003.
13. Thorstensen L, Diep C, Meling G, Aagesen T, Ahrens C, Rognum T and Lothe R: WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology 121: 1275-1280, 2001.
14. Davis L, Chen Y and Sen M: WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem Biophys Res Commun 342: 259-265, 2006.
15. Hanavadi S, Martin T, Mansel R and Jiang WG: Interleukin-11 and its receptor expression in human breast cancer. Ann Surg Oncol 13: 802-808, 2006.
16. Martin T, Goyal A, Mansel R, Watkins G and Jiang WG: The transcription factor for the E-cadherin complex, Twist, Slug and Snail, in human breast cancer. Ann Surg Oncol 12: 1-9, 2005.
17. Jiang WG, Watkins G, Lane J, Cunnick G, Douglas-Jones A, Mokbel K and Mansel RE: Prognostic value of Rho family and rho-GDIs in breast cancer. Clin Cancer Res 9: 6432-6440, 2003.
18. Nazarenko A, Bhatnagar S and Hohman R: A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acid Res 25: 2516-2521, 1997.
19. Jiang WG, Douglas-Jones A and Mansel RE: Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int J Cancer 106: 752-757, 2003.
20. Ye L, Martin T, Parr C, Harrison G, Mansel R and Jiang WG: Biphasic effects of 17-β-estradiol on expression of occluding and transendothelial resistance (TER) and paracellular permeability in human vascular endothelial cells. J Cell Physiol 196: 362-369, 2003.
21. King J, Ofori-Acquash A, Stevens T, Al-Mehdi A, Fodstad O and Jiang WG: Activated leukocyte adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6: 478-487, 2004.
22. Parr C, Watkins G and Jiang WG: The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinico-pathological parameters in human breast cancer. Int J Mol Med 14: 779-786, 2004.
23. Jiang WG, Grimshaw D, Lane J, Martin T, Abounader R, Laterra J and Mansel RE: A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res 7: 2555-2562, 2001.
24. Davies G, Jiang WG and Mason M: Cell-cell adhesion and signalling intermediates in human prostate cancer. J Urol 163: 985-992, 2003.
25. Davies SR, Watkins G, Mansel RE and Jiang WG: Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human breast cancer and the prognostic implications. Ann Surg Oncol 14: 1909-1918, 2007.
26. Dukes CE: The surgical pathology of rectal cancer. Am J Surg 1950: 66-71, 1950.
27. Xie D, Nakachi K, Wang H, Elashoff R and Koeffler P: Elevated levels of connective tissue growth factor, WISP-1 and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61: 8917-8923, 2001.
28. Babic A, Kireeva M, Kolesnikova T and Lau L: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95: 6355-6360, 1998.
29. Mason H, Lake A, Wubben J, Nowak R and Castellot J Jr: The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod 10: 181-187, 2004.
30. Zoubine M, Banerjee S, Saxena N, Campbell D and Banerjee S: WISP-2: a serum-induible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. Biochem Biophys Res Commun 282: 421-425, 2001.
31. Thorstenesen L, Diep CB, Meling GI, Aagesen TH, Ahrens CH, Rognum TO and Lothe RA: WNT1 inducible signalling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology 121: 1275-1280, 2001.
32. Van Golen K, Davies S, Wu Z, et al: A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5: 2511-2519, 1999.